Purchase Order 75N91023P00550
Award Date 7/6/23
Potential Completion Date 9/5/23
Potential Value $24K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Seattle, WA 98109, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm-fixed-price contract award to Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science research tools. The contract, valued at $8,832.00, was awarded by the National Cancer Institute, a component of the National Institutes of Health, and does not have a set-aside designation. Nanostring will provide the agency with its proprietary nCounter and GeoMx analysis systems, as well as associated reagents, assays, and testing...
- Nanostring Technologies, Inc. received a $20,442.50 firm fixed-price blanket purchase agreement (BPA) call from the National Cancer Institute on April 12, 2024, with completion scheduled for July 12, 2024. This supplies contract, which carries no set-aside designation, represents a task order under an existing BPA vehicle and will be performed in Seattle, Washington. The award supports the National Cancer Institute's research mission by providing specialized genomic analysis products or services...
- The Department of Health and Human Services, National Institutes of Health, National Cancer Institute awarded a firm-fixed-price purchase order to Nanostring Technologies, Inc., a for-profit manufacturer of life science tools, for the provision of NanoString GeoMX Digital Spatial Profiling and nCounter MAX System equipment and services to support the Laboratory of Pathology's Single-Cell RNA Facility. The $496,250 contract has a completion date of September 3, 2020 and does not utilize a...
- The National Cancer Institute awarded a $24,743 firm fixed price Blanket Purchase Agreement (BPA) call to NanoString Technologies, Inc. for biological kits on April 30, 2024, with an ultimate completion date of May 29, 2024. The contract, which carries no set-aside designation, will be performed in Seattle, Washington. NanoString Technologies is a publicly traded provider of advanced genomic analysis platforms and life science tools, specializing in multiplexed digital detection technologies...
- Nanostring Technologies, Inc., a publicly traded provider of advanced genomic analysis platforms and life science tools, was awarded a $22.3K blanket purchase agreement (BPA) call by the National Cancer Institute on June 5, 2024, for laboratory supplies. The contract is firm fixed-price with no set-aside designation and is scheduled for completion by September 30, 2024. The work will be performed at the contractor's Seattle, Washington facility. This award represents a continuation of...
- Nanostring Technologies, Inc. was awarded a $20.3K blanket purchase agreement (BPA) call by the National Cancer Institute on July 14, 2017, with an ultimate completion date of August 13, 2017. This firm fixed-price contract, which utilized no set-aside designation, represents a delivery order against an existing BPA vehicle and will be performed at the contractor's facility in Bethesda, MD. Nanostring is a leading provider of advanced genomic analysis platforms and life science tools,...
- Nanostring Technologies, Inc. received a $24,357 fixed-price contract with economic price adjustment from the National Cancer Institute (NCI) on June 26, 2018, with an ultimate completion date of May 14, 2019. This award was issued as a Blanket Purchase Agreement (BPA) call without a set-aside designation and is for performance in Bethesda, Maryland. As a leading provider of advanced genomic analysis platforms and life science tools, Nanostring supplies specialized laboratory equipment,...
- The National Cancer Institute awarded a $24,339.03 firm fixed-price blanket purchase agreement (BPA) call to Nanostring Technologies, Inc. for biological and reagent materials. The contract was executed on April 23, 2024, with an ultimate completion date of May 22, 2024, and is being performed in Seattle, Washington. This award carries no set-aside designation and represents a call against an existing BPA vehicle, allowing the government to procure specialized genomic analysis reagents and...
- Nanostring Technologies, Inc. was awarded a firm fixed price contract valued at $24,818.90 by the National Institute of Environmental Health Sciences on August 10, 2020, with an ultimate completion date of September 8, 2020. This award was issued as a call under an existing blanket purchase agreement (BPA) and did not utilize any set-aside designation. The contract is for products and services related to Nanostring's advanced genomic analysis platforms, which the vendor supplies to support the...
- This federal contract award to Nanostring Technologies, Inc. is for the provision of the NANOSTRING HUMAN MIRNA ASSAY KIT, valued at $10,789.01. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services. The contract is a firm fixed-price purchase order with a completion date of September 29, 2015. Nanostring Technologies is a publicly traded provider of advanced genomic analysis platforms...